| dc.creator |
Yildirim, Mustafa |
|
| dc.creator |
KAYA, Vildan |
|
| dc.creator |
PAYDAŞ, SEMRA |
|
| dc.creator |
Demirpence, Ozlem |
|
| dc.date |
2014-12-31T22:00:00Z |
|
| dc.date.accessioned |
2020-10-06T10:47:07Z |
|
| dc.date.available |
2020-10-06T10:47:07Z |
|
| dc.identifier |
850521f9-6662-45b4-9634-948ea68e16a1 |
|
| dc.identifier |
10.5114/aoms.2015.53289 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/850521f9-6662-45b4-9634-948ea68e16a1/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/65198 |
|
| dc.description |
Introduction: Diffuse large B cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL). Although gender has not been included in prognostic systems, male gender has been found as a bad prognostic indicator in Hodgkin lymphoma, follicular lymphoma and chronic lymphocytic leukemia. The relationship between gender and prognosis is not clear in patients with DLBCL treated with rituximab-containing regimens. The aim of this meta-analysis is to determine the prognostic/predictive role of gender in patients with DLBCL treated with rituximab-containing regimens. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/openAccess |
|
| dc.title |
The role of gender in patients with diffuse large B cell lymphoma treated with rituximab-containing regimens: a meta-analysis |
|
| dc.type |
info:eu-repo/semantics/article |
|